ICON runs clinical trials for drugmakers.
ICON Public Limited Company (ICLR) is expected to report earnings on Tuesday, October 27, 2026, after the close. Estimated release time after close. Consensus EPS estimate is $2.65.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-29 | Jun 2026 qtr | $2.55 | $2.35 | -7.8% | $2.06B |
| 2026-05-27 | Dec 2025 qtr | $3.13 | $1.95 | — | $2.11B |
| 2025-10-22 | Sep 2025 qtr | $3.28 | $3.31 | +0.9% | $2.04B |
| 2025-07-24 | Jun 2025 qtr | $3.19 | $2.31 | — | $2.02B |
| 2025-05-02 | Mar 2025 qtr | $3.11 | $3.19 | +2.6% | $2.00B |
| 2025-02-21 | Dec 2024 qtr | $3.41 | $3.18 | -6.7% | $2.04B |
| 2024-10-23 | Sep 2024 qtr | $3.84 | $3.35 | -12.8% | $2.03B |
| 2024-07-24 | Jun 2024 qtr | $3.68 | $3.75 | +1.9% | $2.12B |
ICLR has beaten consensus EPS in 3 of its last 6 scored quarters.
See ICLR on the live calendar →